Supersensitivity of brain opiate receptor subtypes after chronic naltrexone treatment.
D000818:Animals; D001665:Binding Sites / Q000187:drug effects; D001921:Brain / Q000187:drug effects*; D006801:Humans; D009270:Naloxone / Q000031:analogs & derivatives*; D009271:Naltrexone / Q000008:administration & dosage / Q000494:pharmacology*; D009293:Opioid-Related Disorders; D051381:Rats; D011957:Receptors, Opioid / Q000032:analysis / Q000187:drug effects*; D017473:Receptors, Opioid, kappa; D017450:Receptors, Opioid, mu; D013375:Substance Withdrawal Syndrome; D013997:Time Factors
D011957:Receptors, Opioid; D017473:Receptors, Opioid, kappa; D017450:Receptors, Opioid, mu; D009270:Naloxone; D009271:Naltrexone